Clinical trial

[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers

NCT04320030

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-06-11

PhasePHASE2

Study timeline

Study start (actual)2020-06-11Date precision: day

Registry last updated2023-02-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Triple Negative Breast Cancerunresolved

Interventions

[18F]-DPA-714 PET/CT scanDRUG

Sponsors & collaborators

Institut Cancerologie de l'Ouestlead sponsor

SIRIC ILIADcollaborator

Mapped research locations

ParisFrance1 Saint-HerblainFrance1 ToursFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04320030 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.